美聯工商鋪(00459.HK)擬2780萬港元收購香港物業
格隆匯5月14日丨美聯工商鋪(00459.HK)公吿,於2021年5月14日,物業買方金帝國際有限公司(公司全資附屬公司)、物業賣方麗萊時裝有限公司及代理訂立物業收購協議,據此,物業買方同意收購該物業,收購代價為港幣2780萬元,將以現金分期付款。
物業包括香港九龍太子道西157號別樹華軒地下3號鋪,建築面積約356平方尺。
收購符合集團的策略,並代表集團現有物業投資業務的擴展。預期物業將予繼續出租以賺取租金收入,並將為集團提供額外及穩定的租金收入。收購使集團得以進一步拓闊收入來源以及可享有物業的潛在資本增值。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.